Journal article
The genetic reconstruction of BCG as a new immunotherapeutic tool
Trends in biotechnology (Regular ed.), Vol.15(12), pp.512-517
1997
DOI: 10.1016/S0167-7799(97)01134-7
PMID: 9418306
Abstract
The bacillus of Calmette and Guérin (BCG), long appreciated for its role as a live vaccine for the prevention of tuberculosis, is undergoing a rebirth as a recombinant delivery vehicle for foreign antigens and bioactive proteins. Recombinant BCG causes long-lived specific humoral and cellular immunity and may ultimately prove to be a powerful and cost-effective new weapon against both infectious pathogens and certain cancers.
Details
- Title: Subtitle
- The genetic reconstruction of BCG as a new immunotherapeutic tool
- Creators
- Michael A. O'Donnell - Beth Israel Deaconess Medical Center
- Resource Type
- Journal article
- Publication Details
- Trends in biotechnology (Regular ed.), Vol.15(12), pp.512-517
- Publisher
- Elsevier Ltd
- DOI
- 10.1016/S0167-7799(97)01134-7
- PMID
- 9418306
- ISSN
- 0167-7799
- eISSN
- 1879-3096
- Language
- English
- Date published
- 1997
- Academic Unit
- Urology
- Record Identifier
- 9984320062602771
Metrics
3 Record Views